+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Milrinone (CAS 78415-72-2) Global Market Research Report 2024

  • PDF Icon

    Report

  • 50 Pages
  • November 2024
  • Region: Global
  • Merchant Research and Consulting Ltd
  • ID: 4179673
Description Jump to:
This global report is a result of industry experts’ diligent work on researching the world market of Milrinone. The report helps to build up a clear view of the market trends and developments, identify major players in the industry, and estimate main downstream sectors.

The Milrinone global market report's key points:

  • Milrinone description, applications and related patterns
  • Milrinone market situation
  • Milrinone manufacturers and distributors
  • Milrinone prices
  • Milrinone end-users
  • Milrinone downstream industries trends
The first chapter introduces the product (composition, structure, hazards, storage, toxicological & ecological information, etc.).

The second chapter focuses on Milrinone end-uses. The third chapter summarizes data about manufacturing methods.

The fourth chapter is about the related patents. The fifth chapter deals with Milrinone market trends and forecast, distinguish Milrinone manufacturers and suppliers.

The sixth chapter provides Milrinone prices data.

The seventh chapter analyses Milrinone downstream markets.


This product will be delivered within 5-7 business days.

Table of Contents

1. MILRINONE GENERAL INFORMATION
1.1. General information, synonyms
1.2. Composition, chemical structure
1.3. Safety information
1.4. Hazards identification
1.5. Handling and storage
1.6. Toxicological & ecological information
1.7. Transport information

2. MILRINONE APPLICATIONS

3. MILRINONE MANUFACTURING METHODS

4. MILRINONE PATENTS

5. MILRINONE MARKET WORLDWIDE
5.1. Global Milrinone market analysis: market constraints, drivers and opportunities
5.2. Manufacturers of Milrinone
  • Europe
  • Asia
  • North America
  • Etc.
5.3. Suppliers of Milrinone
  • Europe
  • Asia
  • North America
  • Etc.
5.4. Market forecast

6. MILRINONE MARKET PRICES
  • Europe
  • Asia
  • North America
7. MILRINONE END-USE SECTOR

Related Topics

Related Reports

Heart Failure - Pipeline Insight, 2024 - Product Image

Heart Failure - Pipeline Insight, 2024

  • Clinical Trials
  • 300 Pages
  • Global
From
Inotropic Agents Global Market Report 2024 - Product Image

Inotropic Agents Global Market Report 2024

  • Report
  • 200 Pages
  • Global
From
Berbamine (CAS 478-61-5) Global Market Research Report 2024 - Product Image

Berbamine (CAS 478-61-5) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Budralazine (CAS 36798-79-5) Global Market Research Report 2024 - Product Image

Budralazine (CAS 36798-79-5) Global Market Research Report 2024

  • Report
  • 50 Pages
  • Global
From
Esmolol Hydrochloride Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Esmolol Hydrochloride Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 80 Pages
  • Global
From

About the Milrinone Market

Milrinone is a cardiovascular drug used to treat heart failure and other cardiac conditions. It is a type of inotropic agent, meaning it increases the force of contraction of the heart muscle. It is administered intravenously and is used to improve cardiac output and reduce pulmonary congestion. Milrinone is also used to treat cardiogenic shock, a life-threatening condition in which the heart is unable to pump enough blood to meet the body's needs. Milrinone is a relatively new drug, having been approved by the FDA in 1991. It is used in both inpatient and outpatient settings, and is often used in combination with other drugs to treat heart failure. The Milrinone market is highly competitive, with several major pharmaceutical companies producing and marketing the drug. These include Pfizer, Novartis, Merck, and Sanofi. Other companies, such as Mylan and Teva, also produce generic versions of the drug. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.